TB-500 is commonly studied for its association with cellular migration, tissue remodeling, actin regulation, and regenerative processes
Track Live FDA Peptide Status Regulatory status changes as PCAC hearings and FDA determinations roll out
IV Therapy allows us to achieve maximum effect, working at a faster and more effective rate, delivering directly to the cells
This is where working with specialists becomes invaluable, as they can design integrated protocols that address your complete health picture
Phase I escalation and expansion study of bemarituzumab (FPA144) in patients with advanced solid tumors and FGFR2b-selected gastroesophageal adenocarcinoma
Leveraging an arsenal of advanced treatments, our experienced team of medical professionals specializes in helping patients achieve optimal wellness inside and out